HEPA
Hepion Pharmaceuticals
HEPA
HEPA
Delisted
HEPA was delisted on the 12th of May, 2025.
6 hedge funds and large institutions have $215K invested in Hepion Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 2 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
6
Holders Change
+2
Holders Change %
+50%
% of All Funds
0.13%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
1
Reduced
1
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
Barclays
London,
United Kingdom
|
+$33.3K |
2 |
Citadel Advisors
Miami,
Florida
|
+$27K |
3 |
VF
Virtu Financial
New York
|
+$16K |
Top Sellers
1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$116K |
2 |
![]()
JPMorgan Chase & Co
New York
|
-$14K |
3 |
Northern Trust
Chicago,
Illinois
|
-$11K |
4 |
CS
Credit Suisse
Zurich,
Switzerland
|
-$11K |
5 |
UBS Group
Zurich,
Switzerland
|
-$5K |